miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4

Highlights of this study • MiR-187-3p is significantly down-regulated in HCC, and is correlated with adverse clinical features and poor prognosis of HCC patients. • MiR-187-3p can inhibit the metastasis of HCC cells by regulating EMT phenotype. • S100A4 is a direct downstream target of miR-187-3p, a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 2016-10, Vol.381 (2), p.380-390
Hauptverfasser: Dou, Changwei, MD, Liu, Zhikui, MD, Xu, Meng, MD, Jia, Yuli, MD, Wang, Yufeng, MD, Li, Qing, MD, Yang, Wei, PhD, MD, Zheng, Xin, PhD, MD, Tu, Kangsheng, PhD, MD, Liu, Qingguang, PhD, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights of this study • MiR-187-3p is significantly down-regulated in HCC, and is correlated with adverse clinical features and poor prognosis of HCC patients. • MiR-187-3p can inhibit the metastasis of HCC cells by regulating EMT phenotype. • S100A4 is a direct downstream target of miR-187-3p, and mediated the biological function of miR-187-3p in HCC. • MiR-187-3p can be down-regulated by hypoxia, and is involved in the promoting effects of hypoxia on the metastasis and EMT of HCC cells
ISSN:0304-3835
1872-7980
DOI:10.1016/j.canlet.2016.08.011